Login to Your Account



Financings Roundup

Rigel Doubles Cash with Potential $150M Offering

By Tom Wall


Friday, May 27, 2011
Rigel Pharmaceuticals Inc. could gross nearly $150 million in an underwritten public offering of 16.3 million shares of common stock and an overallotment option for an additional 2.4 million shares at $8 a share, a 5.7 percent discount.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription